title: [Advances in diabetic erectile dysfunction].
abstract: Erectile dysfunction is common complication of diabetes mellitus. The incidence of diabetes mellitus induced erectile dysfunction (DMED) is 20% - 75%. DMED appears to be due to vascular-neuropathic and corpus cavernosum smooth muscular damage. To control blood glucose, blood pressure and blood lipids is the basis of DMED therapy. In 50% of the patients with DMED, the phosphodiesterase 5 inhibitors is effective, while intracavernous pharmacotherapy is effective for more than 90%. Penile prosthesis implantation continues to be the treatment of choice in case of other therapy failure.
authors.affiliation: Department of Gerontology, Second Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong 510260, China.
authors.forename: Shu-Yan
authors.initials: SY
authors.lastname: Huang
authors.forename: Shu
authors.initials: S
authors.lastname: Chen
authors.forename: Yi-Ping
authors.initials: YP
authors.lastname: Feng
mesh_terms: D000818:Animals; D048909:Diabetes Complications / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology; D007172:Erectile Dysfunction / Q000453:epidemiology / Q000473:pathology / Q000628:therapy; D006801:Humans; D008297:Male; D011817:Rabbits; D051381:Rats